Anthony Domingo, M.D.
Endocrinology, Diabetes & Metabolism Physician in Miami, Florida.
This profile is drawn from the federal National Provider Identifier Registry (CMS NPPES), which lists more than 7 million U.S. healthcare providers - including 8,078 in Endocrinology, Diabetes & Metabolism Physician, and covers specialty classification, practice address, and Medicare Part D prescribing data when reported. According to CMS, every field reflects the provider's official federal registration, see our methodology.
Source: CMS Medicare Part D Prescriber Public Use File, 2024
What the federal data shows
Anthony Domingo, M.D. filed 474 Medicare Part D claims in 2024 as an Endocrinology, Diabetes & Metabolism Physician in Miami, Florida, prescribing 11% generic.
- 474
- Part D claims, 2024
- 11%
- generic prescribing
- ≥61st
- pct by Part D claim volume (lower-bound band)
Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) - no proprietary rating or editorial opinion is applied.
Federal trust snapshot
What official records show about Anthony Domingo, M.D.
Federal records show an active NPI with Medicare Part D prescribing activity — verifiable registry data, not a proprietary rating.
- Verified
NPI registry status
Active listing in the CMS National Provider Identifier Registry (NPI 1801069893), first enumerated 04/10/2008.
Source: CMS NPPES
- Reported
Medicare Part D participation
Filed 474 Medicare Part D prescription claims in the 2023 CMS public use file — indicates active Medicare prescribing participation.
Source: CMS Part D Prescriber PUF
- Reported
Board certification signal
Practices in an ABMS-board-eligible specialty; board certification not confirmed in federal records.
- State context
State board disciplinary context
Florida statewide board action statistics are published annually — these figures describe aggregate state activity, not Anthony Domingo, M.D.'s individual license status. Verify directly with the state medical board.
Source: FLDOH annual report 2023
- Not in federal data
Individual sanction lookup
PlainDoctor does not publish per-provider disciplinary determinations. Confirm current license and any individual actions through the state medical board or FSMB verification service.
Source: State medical board / FSMB
This trust snapshot summarizes only what appears in federal CMS/NPPES public records. It is not a composite score, star rating, patient review, or clinical recommendation. PlainDoctor never fabricates reviews or AggregateRating schema.
CMS NPPES provider registry desk
NPI 1801069893 · Endocrinology, Diabetes & Metabolism Physician
NPI-10 · ENUM-MID · TAX-MID · RX-LIGHT · BOOK-LIGHT · PHOTO-ENUM
- NPI-10 1801069893
- ENUM-MID 2008
- TAX-MID 8K Endocrinology, Diabetes
- RX-LIGHT 474
- BOOK-LIGHT 538 in Florida
- PHOTO-ENUM Shervin Yousefian · 2008
Anthony Domingo, M.D.'s Medicare Part D volume vs every U.S. prescriber
Total Medicare Part D claims, 2024, across all CMS prescribers nationally
474 ≥ 61st percentile 61% of 1,416,883 prescribers are in lower value bands
Each bar is a band; taller bars hold more prescribers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
The percentile is a conservative 100-claim band: it counts only prescribers in lower claim-volume bands. Medicare Part D claim volume is activity context, not a quality measure or recommendation. See methodology § corpus placement.
Source CMS Medicare Part D Prescriber Public Use File · 2024
Anthony Domingo, M.D. practices in an ABMS-board-eligible specialty but we don't have enough CMS-participation signals to confirm active board-certified status. Consult CertificationMatters.org (the official ABMS public lookup).
What does the federal data show about Anthony Domingo, M.D.?
Quality data not reportedPrimary specialty
Medicare Part D claims
Specialty distribution in Florida
How Endocrinology, Diabetes & Metabolism Physician compares to other specialties among Florida providers
Endocrinology, Diabetes & Metabolism Physician ranks #98 among Florida's specialties (0.1% of in-state providers)
Each bar is a specialty's share of the Florida provider total, by primary NUCC taxonomy. The highlighted bar is Endocrinology, Diabetes & Metabolism Physician; the long tail of smaller specialties is omitted for legibility.
Board certification
Not published by CMS
CMS does not publish a per-provider board-certification field in NPPES. PlainDoctor does not have a reliable per-specialty certification rate to show for Endocrinology, Diabetes & Metabolism Physician. Verify directly:
How MIPS and board certification work
The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).
Practice Address
Provider Details
| NPI | 1801069893 |
|---|---|
| Specialty | Endocrinology, Diabetes & Metabolism Physician |
| Credentials | M.D. |
| Gender | Male |
| NPI Issued | 04/10/2008 |
Verify this provider's license
PlainDoctor pulls this profile from the CMS NPPES public registry. Confirm Anthony Domingo, M.D.'s current license status, disciplinary history, and board certifications with the Florida Board of Medicine in Florida before relying on this page for a clinical or care decision.
How we sourced this profile
Profile fields combine the CMS NPPES monthly snapshot (provider directory, taxonomy, and address) with calendar-year 2023 Medicare Part D and MIPS public-use files when records are present. NPI 1801069893 is the unique 10-digit identifier CMS uses to link Domingo across every Medicare, Medicaid, and HIPAA-covered transaction. Read full methodology →
License & disciplinary context - Florida FLDOH 2023 annual report
Aggregate state board data only, NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~75K Florida medical licensees in 2023 - they are NOT specific to Anthony Domingo, M.D.. To verify Anthony Domingo, M.D.'s current license status, search the FLDOH public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.
FLDOH publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the Florida disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.
Brand vs generic prescribing mix · Brand-heavy
59% brand-name claims vs 11% generic, on 474 2024 Medicare Part D claims.
The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.
Medicare Part D Prescribing Data
CMS Medicare Part D prescriber-level data for calendar year 2024.
Prescribing Breakdown
- 30-Day Fills
- 630.5
- Total Day Supply
- 18,264
- Brand vs Generic
- 59% brand / 11% generic
- Brand Drug Cost
- $52K
- Generic Drug Cost
- $412
Patient Demographics
- Average Patient Age
- 70.8 years
- Avg HCC Risk Score
- 3.45
- Gender Split
- 58% female / 42% male
- Age Distribution
- <65: 47, 65-74: 70, 75-84: 65, 85+: 20
Top Prescribed Drugs (Medicare Part D)
Top drugs by claim count for calendar year 2024. Based on Medicare Part D data only.
What Anthony Domingo, M.D. prescribes most
Top Medicare Part D drugs by claim count, 2024
- Lantus Solostar
Lantus Solostar
85 claims
- Ultra-Fine Short P…
Ultra-Fine Short Pen Needle
58 claims
- Humalog Kwikpen U-…
Humalog Kwikpen U-100
40 claims
- Ultra-Fine Mini Pe… 32
Ultra-Fine Mini Pen Needle
32 claims
- Tradjenta 26
Tradjenta
26 claims
- Insulin Lispro Kwi… 23
Insulin Lispro Kwikpen U-100
23 claims
- Metformin Hcl 21
Metformin Hcl
21 claims
- Novolog Flexpen 16
Novolog Flexpen
16 claims
| Drug | Claims |
|---|---|
| Lantus Solostar Insulin Glargine,hum.Rec.Anlog | 85 |
| Ultra-Fine Short Pen Needle Pen Needle, Diabetic | 58 |
| Humalog Kwikpen U-100 Insulin Lispro | 40 |
| Ultra-Fine Mini Pen Needle Pen Needle, Diabetic | 32 |
| Tradjenta Linagliptin | 26 |
| Insulin Lispro Kwikpen U-100 Insulin Lispro | 23 |
| Metformin Hcl | 21 |
| Novolog Flexpen Insulin Aspart | 16 |
| Glipizide | 15 |
| Comfort Ez Pen Needle Pen Needle, Diabetic | 14 |
* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.
Endocrinology, Diabetes & Metabolism Physician Overview
How Anthony Domingo, M.D. fits within the Endocrinology, Diabetes & Metabolism Physician landscape nationally.
Anthony Domingo, M.D.'s 474 claims are below the specialty average of 2,739.
Nationwide Endocrinology, Diabetes & Metabolism Physician peers with similar MIPS or enrollment year
Two federal-record peer sets for Domingo, both outside Florida so the neighborhoods are not geographic containment.
Same NPPES enumeration year (2008)
Same-specialty clinicians who entered the NPI registry in the same calendar year, outside this state.
Nearby Endocrinology, Diabetes & Metabolism Physician Providers in Florida
Other clinicians with the same primary specialty enrolled in Florida, drawn from the same CMS NPPES roster as Domingo.
One of 538 Endocrinology, Diabetes & Metabolism Physician providers enrolled in Florida, 5 are shown here.
Compare Endocrinology, Diabetes & Metabolism Physician nationally: see state-by-state distribution →
Frequently Asked Questions
What is Anthony Domingo, M.D.'s specialty? ▼
How much does Anthony Domingo, M.D. prescribe under Medicare Part D? ▼
Where is Anthony Domingo, M.D. located? ▼
What is Anthony Domingo, M.D.'s NPI number? ▼
Does Anthony Domingo, M.D. prescribe more brand-name or generic drugs? ▼
How many Endocrinology, Diabetes & Metabolism Physician providers are there in the US? ▼
What drugs does Anthony Domingo, M.D. prescribe most often? ▼
Does Anthony Domingo, M.D. accept Medicare? ▼
How can I verify Anthony Domingo, M.D.'s credentials? ▼
Data Sources
View source datasets and methodology notes
- Provider Directory
- CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
- Specialty Classification
- NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
- Prescribing Data
- CMS Medicare Part D Prescriber Public Use File (2024). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
- Limitations
- Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.
See our complete data methodology for details on how we collect and process government data.
Data as of August 2026 (NPPES) / 2024 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).
Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology
Every figure on PlainDoctor is rendered directly from the federal CMS NPPES registry, Medicare Part D, MIPS, and Open Payments records, no number is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of August 2026.
Published by
PlainDoctor
Independent public-data reference that compiles, verifies, and contextualizes official datasets. We do not accept compensation from entities we cover, and every dataset cites its originating public source.